Implications Beyond ALS The shared protein-misfolding pathology across neurological disorders suggests BTT’s intelligent programmed fever therapy can be utilized for the treatment of other ...
BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ...
An Arizona veteran who learned he has ALS is exploring a new blood test that researchers at UCLA are studying.
Researchers say the new blood test would allow for earlier screening and thus could increase life expectancy. Casey Torres ...
The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...
Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.
Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price. The South ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results